Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes. In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time. Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors. We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compound, R848. We detected direct binding of antimalarials to nucleic acids by spectroscopic experiments and determined their cellular colocalization. Further analysis revealed that other nucleic acid-binding compounds, such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes. We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials. In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition. We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compounds in the treatment…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In phagocytic cells, the deacidification of endosomes using pharmacological inhibitors like chloroquine has been shown to reduce endosomal toll-like receptor (TLR) response (de Bouteiller et al., 2005; Fox, 2019; Kuznik et al., 2011; Wozniacka et al., 2006; Yang et al., 2016)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Kuznik et al., 2011
In the citing paper
“Hydroxychloroquine (HCQ) is an approved anti-malaria drug, and accumulation of hydroxychloroquine inhibits the binding ability of TLR9 to DNA and subsequent immune activation (77).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [77]
Citations
Cites
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617
Boulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner
Rutz, M., Metzger, J., Gellert, T., Luppa, P., Lipford, G. B., Wagner, H., & Bauer, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200425218 · Cited by 503
Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y.-M., & Ploegh, H. L. (2008) · Nature Immunology · doi:10.1038/ni.1669 · Cited by 480
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 465
Vacuolar ATPase activity is required for endosomal carrier vesicle formation.
Clague, M. J., Urbé, S., Aniento, F., & Gruenberg, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42302-7 · Cited by 416
Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Krieg, A. M., & Vollmer, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00572.x · Cited by 350
Yi, A.-K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4755 · Cited by 328
MECHANISMS OF CHROMOSOME BANDING AND IMPLICATIONS FOR CHROMOSOME STRUCTURE
Comings, D. E. (1978) · Annual Review of Genetics · doi:10.1146/annurev.ge.12.120178.000325 · Cited by 316
Vallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Macfarlane, D. E., & Manzel, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1122 · Cited by 261
Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 256
Wang, J. P., Liu, P., Latz, E., Golenbock, D. T., Finberg, R. W., & Libraty, D. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7114 · Cited by 207
The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer
Båve, U., Alm, G. V., & Rönnblom, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3519 · Cited by 167
Antimalarial drugs in the treatment of rheumatological diseases.
Rynes, R. I. (1997) · Rheumatology · doi:10.1093/rheumatology/36.7.799 · Cited by 167
Systemic lupus erythematosus and the type I interferon system.
Rönnblom, L., & Alm, G. V. (2003) · Arthritis Research · doi:10.1186/ar625 · Cited by 158
Umata, T., Moriyama, Y., Futai, M., & Mekada, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45829-2 · Cited by 156
Wallace, D. J. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00233-7 · Cited by 152
TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Karlsson, L., Sun, S., Rao, N. L., Venable, J. D., & Thurmond, R. L. (2007) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152807783334300 · Cited by 133
Human Lymphatic Endothelial Cells Express Multiple Functional TLRs
Pegu, A., Qin, S., Junecko, B. A. F., Nisato, R. E., Pepper, M. S., & Reinhart, T. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3399 · Cited by 126
Handbook of Experimental Pharmacology
Haberkorn, U. (2008) · doi:10.1007/978-3-540-77496-9-2 · Cited by 116
TLR9 and the Recognition of Self and Non‐Self Nucleic Acids
Lamphier, M. S., Sirois, C. M., Verma, A., Golenbock, D. T., & Latz, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.005 · Cited by 114
Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines
Gorden, K. B., Qiu, X., Battiste, J. L., Wightman, P. D., Vasilakos, J. P., & Alkan, Ş. Ş. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8164 · Cited by 103
Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know?
O'Neill, L. A. J. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0802 · Cited by 93
A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation
Pirher, N., Ivičak‐Kocjan, K., Pohar, J., Benčina, M., & Jerala, R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1453 · Cited by 70
Self-citationLeite‐de‐Moraes, M., Lisbonne, M., Arnould, A., Machavoine, F., Herbelin, A., Dy, M., & Schneider, E. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1839::aid-immu1839>3.0.co;2-y · Cited by 53
Berghöfer, B., Haley, G., Frommer, T., Bein, G., & Hackstein, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4072 · Cited by 44
The Interaction of Acridines with Nucleic Acids
PEACOCKE, A. R. (1973) · The chemistry of heterocyclic compounds/The Chemistry of heterocyclic compounds · doi:10.1002/9780470186596.ch15 · Cited by 43
Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter, G., Kužnik, A., & Jerala, R. (2009) · PubMed · Cited by 40
Self-citationNucleic Acid Recognition Receptors in Autoimmunity
Krug, A. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_7 · Cited by 35
Manzel, L. J., Strękowski, L., Ismail, F. M. D., Smith, J. C., & Macfarlane, D. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35244-9 · Cited by 31
Research works printed but not linked: 2
- Ahmad-Nejad, 2002, Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · DOI · Paper page
- Peacocke, 1973, Acridines, 723
Cited by
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology
Schrezenmeier, E., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0372-x · Cited by 1,468
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 754
Lysosomes as a therapeutic target
Bonam, S. R., Wang, F., & Muller, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0036-1 · Cited by 759
Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis
Thwaites, R., Chamberlain, G., & Sacre, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00001 · Cited by 748
Metadata
- Authors
- Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R.
- Affiliations
- National Institute of Chemistry (SI)
- Blood Transfusion Centre of Slovenia (SI)
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04
- Volume
- 186
- Issue
- 8
- Pages
- 4794-4804
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2118400571
- Cited by
- 606
- References
- 40
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 43 · 2023: 30 · 2022: 42 · 2021: 69 · 2020: 89 · 2019: 38 · 2018: 39 · 2017: 38 · 2016: 41 · 2015: 43 · 2014: 32 · 2013: 22 · 2012: 28
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- antimalarial drugs, imidazoquinolines, chloroquine, hydroxychloroquine, quinacrine, TLR8, R848, nucleic acid binding, endosomal acidification, TLR9, TLR3, TLR7/8 agonist, systemic lupus erythematosus, autoimmune disease therapy, propidium iodide, bafilomycin
- MeSH terms
- Animals, Antimalarials, Binding, Competitive, Cell Line, Cells, Cultured, Chloroquine, Culture Media, Humans, Hydrogen-Ion Concentration, Imidazoles, Nucleic Acids, Quinacrine, Quinolines, Endosomes, Transfection, Cytokines, Serum, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 7, Toll-Like Receptor 8, Toll-Like Receptor 9, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.